TX-FLUENCE
Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced it will have a major presence at MJBizCon, the leading cannabis industry conference. Fluence Cannabis Solutions Architect Casey Rivero will join a panel alongside Fluence customers to discuss how growers can maximize crop quality. In addition, the company is investing in connecting the cannabis community at this year’s conference, providing product demonstrations from Fluence’s line of leading LED lighting solutions as well as hosting a series of Grower Talks with Fluence experts at the company’s booth.
Moderated by MJBizDaily reporter Solomon Israel, Rivero’s session, entitled “Powering Through Market Conditions: How Growers in Established Markets are Doubling Down on Quality and Boosting Their Bottom-Line,” will provide growers with concrete steps they can take to navigate an uncertain market. Rivero, a former cannabis cultivator, will be joined by Travis Higginbotham, StateHouse vice president of cultivation; Chris Castle, COO and co-founder of Flora & Flame; Andrew Reich, division manager at SunMed Growers; and Tyler Smith, principal advisor at Smith Cultivations. The panel will take place from 10 to 10:40 a.m. PST on Thursday, Nov. 30 in room N259.
“Though I have had my own grows for years, I find myself learning every single day from the cultivators we collaborate with,” Rivero said. “I’m honored to sit beside some of the industry’s most successful and innovative growers and share our firsthand knowledge on what it takes to deliver the highest-quality product to the market.”
The company will also host a series of Grower Talks throughout the show at the Fluence booth (No. 43023). As part of the series, growers can learn about innovative HPS retrofitting strategies, intercanopy lighting solutions and other topics top of mind in the cannabis industry. Growers will have the opportunity to ask questions and solicit advice from experts in their field, including Taylor Kirk and Dr. Jason Matlock from Fluence's Horticulture Services division, as well as Dr. David Hawley, principal scientist and head of Fluence's Crop Research division. For a detailed list of sessions, including times and featured experts, visit Fluence’s social media the week of the show.
“MJBizCon is an opportunity for the brightest minds in cannabis to come together and share the latest innovations across every facet of the industry,” said Lorrie Schultz, senior vice president of marketing for Fluence. “We’re looking forward to amplifying the voices of our customers as well as sharing insights from our in-house cannabis experts to showcase how Fluence’s LED technology can help cultivators grow smarter, more efficiently and at the highest quality.”
Fluence experts will also demo products from the company’s suite of LED technologies, including its RAPTR, VYPR, SPYDR, RAZR and VYNE fixtures—each designed to make cannabis growers’ lives easier. According to Fluence and Cannabis Business Times’ recently released “State of the Cannabis Lighting Market” report, growers are addressing ongoing industry challenges by redoubling their focus on crop quality. Fluence’s LED technology and cultivation expertise helps cannabis growers throughout the world improve bud density and quality and drive financial success.
For more information on Fluence, stop by the company’s MJBizCon booth in Las Vegas, No. 43023, between Nov. 28 and Dec. 1—or visit www.fluence-led.com.
About Fluence
Fluence Bioengineering, Inc. (Fluence) creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. Fluence operates as a business unit within Signify’s Digital Solutions division. For more information about Fluence, visit www.fluence-led.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231116207472/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
MarkLines Gen-AI Beta Version Released for Automotive Industry13.1.2026 01:00:00 CET | Press release
MarkLines Co., Ltd. (Headquarters: Minato-ku, Tokyo; President & CEO: Makoto Sakai; TYO:3901) announced its launch of the "MarkLines Gen-AI Beta Version," the new feature for B2B users in the automotive industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112383839/en/ "MarkLines Gen-AI Beta Version" can take questions in natural language and instantly give highly reliable, relevant data drawn from MarkLines’ extensive automotive database (Image: MarkLines Co., Ltd.) This AI-powered feature enables users to ask questions in natural language and instantly receive highly reliable, relevant data drawn from MarkLines’ extensive automotive database. Moreover, the system analyzes this information by leveraging the rich content across its platform and delivers clear, concise, text-based insights. By combining trusted data with advanced analytical capabilities through generative AI, this service represents a first-of-its-kind
Australian Defence Force Secures Satellite Communications on SES IS-2212.1.2026 22:30:00 CET | Press release
New agreement for uninterrupted UHF connectivity for Australian Defence Force through 2033, With Options Extending to 2041 Satellite communications solutions provider SES will provide secure uninterrupted satellite communications to the Australian Defence Force (ADF) for a minimum of 16 years thanks to a new extended agreement. The service will be provided via the SES Intelsat 22 satellite and an ultra-high frequency (UHF) military communications payload. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112137182/en/ Assistant Secretary Space Systems Branch, Michael Hunt, formalizes contract negotiations for the through-life support of the IS-22 satellite with Rory Welch, senior vice-president of service delivery at SES Space and Defense. Photos: Corporal Annika Smit Under the renewed arrangement, SES will reposition the IS-22 satellite to a new orbital slot specified by the ADF, continuing a mission that has been the corne
NetApp Appoints Paul Fipps to the Board of Directors12.1.2026 22:05:00 CET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced that Paul Fipps, President of Global Customer Operations at ServiceNow, has joined its Board of Directors. The board now has ten directors, nine of whom are independent, and 50% of whom have been appointed within the last five years. Fipps brings more than 20 years of experience driving technology-enabled growth and customer transformation. At ServiceNow, he currently leads global sales, customer success, partner ecosystems, and field operations. He previously served as EVP of Worldwide Sales at ServiceNow and as President of Under Armour Connected Fitness and Chief Experience Officer at Under Armour, overseeing global direct-to-consumer, connected fitness, and digital experiences. He also previously served on the advisory board of Quantum Metric. Fipps holds a B.S. in Information Systems, an MBA from the University of Baltimore, and is a graduate of The Wharton School’s Advanced Management Program. “P
FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor12.1.2026 20:00:00 CET | Press release
Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s new drug application (NDA) for pimicotinib as a systemic treatment for patients with tenosynovial giant cell tumor (TGCT). The application is based on the primary results and longer-term follow-up of the global Phase 3 MANEUVER study, which demonstrated deep and durable tumor responses and meaningful improvements in clinical outcomes with pimicotinib. “With pimicotinib, we have an opportunity to significantly advance care for people living with TGCT, a painful and debilitating disease that has few effective and well-tolerated treatment options beyond surgery,” said David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “Based on clinical trial results showing not only a reduction in tumor burden, but also the ability to help alleviate symptoms like pain an
Fabentech receives Marketing Authorization for Ricimed®, an antidote against ricin poisoning12.1.2026 19:32:00 CET | Press release
First Marketing Authorization granted in France for the treatment of ricin poisoning, one of the most toxic natural substances in the world and a recognized priority biological threat. Ricimed® addresses a previously unmet medical need in the management of severe and potentially fatal ricin intoxications.Supported by the French Ministry of the Armed Forces and Veterans Affairs (the Directorate General of Armaments and the French Military Health Service), the development of Ricimed® illustrates Fabentech’s transition to a new scale and, with recent support from the European HERA Invest program, reinforces its positioning as a reference player in medical countermeasures against biological threats, serving both civilian and military markets. Fabentech, a French biopharmaceutical company specializing in medical countermeasures against biological threats, today announces that it has been granted Marketing Authorization for Ricimed®, a treatment for ricin poisoning. This press release featur
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom